Breakthrough Designation for BONESUPPORT CERAMENT G for Trauma
CERAMENT G is classified as a breakthrough device for the indication osteomyelitis since March 2020....
Jun 17, 2021,
Orthobiologics
ORTHOFLASH 
Elute Authorized for Clinical Trial of Antibiotic Eluting Bone Void Filler
Elute received authorization from FDA to use its EP Granules with Tobramycin in a pivotal clinical trial....
Jun 08, 2021,
Ortho Regenerative Technologies Receives Clinical Hold Letter From FDA
FDA requested data related to an application to begin a Phase I/II clinical trial for ORTHO-R as an adjunct to...
Jun 04, 2021,
OrthoCell Granted Patents for CelGro Collagen Rope in China and Hong Kong
Orthocell was granted patents for its CelGro collagen rope in China and Hong Kong, bringing the number of countries in...
May 27, 2021,
Study Results: Bioventus Placental Tissue Biologic Candidate
The biologic candidate demonstrated significant reduction of pain and cartilage degeneration in a rat osteoarthritis model....
May 25, 2021,
Prosidyan Gains CE Mark for FIBERGRAFT Bone Grafts
FIBERGRAFT BG Putty, FIBERGRAFT BG Putty GPS and FIBERGRAFT BG Morsels are intended for use in the lumbar and anterior...
May 21, 2021,
Paragon 28 Launches 3 Families of Demineralized Bone Matrix
The company introduced BEAST Injectable, BEAST PLUS and BEAST Osteobiologic Sponge for bone grafting applications in the foot and ankle....
May 21, 2021,
Biogennix Agilon Moldable Bone Graft Available Throughout the U.S.
The product surged in popularity and usage in 2021, largely driven by its positive reception from the foot and ankle...
May 20, 2021,
VIVEX Biologics Launches VIAGENEX Family of Allografts
VIAGENEX has application as a soft tissue barrier in clinical settings such as shoulder, nerve, knee and tendon repair....
May 20, 2021,
Seikagaku Launches JOYCLU Joint Function Agent in Japan
JOYCLU is approved to treat knee and hip osteoarthritis and by intra-articular injection once every four weeks....
May 20, 2021,
Loading new posts...
No more posts
